Glimepiride D4 | CAS 1131981-29-7 - Request Quote
Glimepiride D4
| SZ CAT No: | SZ-G008D01 |
| CAS No | 1131981-29-7 |
| Mol.F. | C24H30D4N4O5S |
| Mol.Wt. | 494.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Glimepiride D4 is chemically 3-Ethyl-4-methyl-N-(2-(4-(N-(((1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenyl)ethyl-1,1,2,2-d4)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide. Glimepiride D4 is supplied with detailed characterization data compliant with regulatory guideline. Glimepiride D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Glimepiride.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1131981-29-7
Purchase 1131981-29-7
Order 1131981-29-7
Enquire 1131981-29-7
price of 1131981-29-7
1131981-29-7 Supplier
1131981-29-7 Manufacturer
1131981-29-7 Exporter
buy high quality Glimepiride D4
Purchase Glimepiride D4
Glimepiride D4 suppliers
Glimepiride D4 manufacturers
Glimepiride D4 price
Order Glimepiride D4
Enquire Glimepiride D4
Glimepiride D4 cost
Glimepiride D4 Supplier
Glimepiride D4 Distributor
Glimepiride D4 for Method Validation
Glimepiride Reference Standard
Glimepiride D4 for ANDA Filing
Glimepiride D4 for Forced Degradation Studies
Glimepiride D4 Identification Standards
Glimepiride D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.